Ursodeoxycholic acid (UDCA) modulates the Bcl-2/Beclin-1 and Bcl-2/Bax complexes via an AMPK pathway, inducing autophagy and impeding the progression of NAFLD (151). This evidence concerns the gene BCL2 and metabolic dysfunction-associated steatotic liver disease.